Stanford-StartX's Zinier took its overall funding to $120m in a round that included returning investor Qualcomm Ventures, with the cash to go to international growth and product development.
Jasper Therapeutics, based in part on Stanford research, has raised a $15m series A extension on the back of early clinical results from its blood transplant conditioning program.
Deep Genomics will use the money to advance drug candidates created through its AI drug development model, based on research by Toronto faculty.
University of Auckland Inventors Fund has contributed to a $40m series B round for AI-based avatar developer Soul Machines, with the investment led by Temasek.
Paige.ai, a Memorial Sloan Kettering spinout, has obtained more than $70m to date and will use the series B to expand its market presence and product line.
Medipal and Sony Innovation Fund by IGV were among the investors that boosted the liver disease drug spinout's latest round to $52.6m.
Space rocket producer LandSpace, a Tsinghua University spinout, has now raised about $200m in all from investors including Xidian University and 36kr Media.
The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.